HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DNA vaccination against macrophage migration inhibitory factor improves atopic dermatitis in murine models.

AbstractBACKGROUND:
Atopic dermatitis (AD) is a common chronic inflammatory skin disease. Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that has been implicated in the pathogenesis of AD. Recently, we developed a novel DNA vaccine that generates neutralizing endogenous anti-MIF antibodies.
OBJECTIVE:
This study explores the preventive and therapeutic effects of this MIF-DNA vaccine in mouse models of AD.
METHODS:
Two different AD model mice (DS-Nh and NC/Nga) received MIF-DNA vaccination to analyze preventive and therapeutic effects, as assessed by clinical skin scores, histologic findings, and serum IgE levels.
RESULTS:
In murine models of AD, MIF-DNA vaccination prevented the occurrence of the AD skin phenotype. Furthermore, administration of MIF-DNA vaccine to mice that had already developed AD produced a rapid improvement in AD skin manifestation. There were reduced histologic signs of inflammation and lower serum IgE levels in treated mice compared with those seen in control animals. Finally, passive transfer of IgG from MIF-DNA vaccinated mice to AD mice also produced a significant therapeutic effect. These results demonstrate that MIF-DNA vaccination not only prevents the development of AD but also improves the symptoms of pre-existing AD.
CONCLUSION:
Taken together, the induction of an anti-MIF autoantibody response using MIF-DNA vaccination appears to be a useful approach in the treatment of AD.
AuthorsAsuka Hamasaka, Riichiro Abe, Yoshikazu Koyama, Naoya Yoshioka, Yasuyuki Fujita, Daichi Hoshina, Mikako Sasaki, Tsutomu Hirasawa, Shin Onodera, Shigeki Ohshima, Lin Leng, Richard Bucala, Jun Nishihira, Tadamichi Shimizu, Hiroshi Shimizu
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 124 Issue 1 Pg. 90-9 (Jul 2009) ISSN: 1097-6825 [Electronic] United States
PMID19482347 (Publication Type: Journal Article)
Chemical References
  • Autoantibodies
  • Macrophage Migration-Inhibitory Factors
  • Tetanus Toxin
  • Tumor Necrosis Factor-alpha
  • Vaccines, DNA
  • Immunoglobulin E
Topics
  • Adoptive Transfer
  • Animals
  • Autoantibodies (immunology)
  • Dermatitis, Atopic (drug therapy, physiopathology, prevention & control)
  • Disease Models, Animal
  • Female
  • Immunoglobulin E (blood)
  • Macrophage Migration-Inhibitory Factors (immunology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Reverse Transcriptase Polymerase Chain Reaction
  • Severity of Illness Index
  • Tetanus Toxin (immunology)
  • Tumor Necrosis Factor-alpha (blood)
  • Vaccines, DNA (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: